Literature DB >> 9710429

Oral ketamine for the management of combative autistic adult.

K L Bachenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9710429     DOI： 10.1097/00000542-199808000-00052

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  3 in total

1.  NMDARs mediate the role of monoamine oxidase A in pathological aggression.

Authors:  Marco Bortolato; Sean C Godar; Miriam Melis; Alessio Soggiu; Paola Roncada; Angelo Casu; Giovanna Flore; Kevin Chen; Roberto Frau; Andrea Urbani; M Paola Castelli; Paola Devoto; Jean C Shih
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

2.  Combination of oral ketamine and midazolam as a premedication for a severely autistic and combative patient.

Authors:  Shailesh Shah; Sonia Shah; Jesus Apuya; Senthil Gopalakrishnan; Timothy Martin
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

Review 3.  Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.

Authors:  Faryal Mallick; Cheryl B McCullumsmith
Journal:  Curr Psychiatry Rep       Date:  2016-06       Impact factor: 5.285
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.